Granada, Spain

Ana Guerra-Librero Rite

This inventor holds 1 USPTO granted patent. Top assignee: Universidad De Granada. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ana Guerra-Librero Rite. Retrieved from https://idiyas.com/inventor/ana-guerra-librero-rite

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ana Guerra-Librero Rite: Innovator in Tumor Treatment

Introduction

Ana Guerra-Librero Rite is a prominent inventor based in Granada, Spain. She has made significant contributions to the field of medicine, particularly in the treatment of tumors. Her innovative approach utilizes melatonin, a hormone known for its role in regulating sleep, to develop a pharmaceutical composition aimed at combating cancer.

Latest Patents

Ana Guerra-Librero Rite holds 1 patent for her groundbreaking invention titled "Use of melatonin for the treatment of tumors." This patent describes a method for preparing a pharmaceutical composition suitable for intratumoral administration. The composition contains high concentrations of melatonin, its derivatives, or metabolites, which exert an oxidizing effect. This effect increases the production of free radicals, thereby activating cell death in tumor cells.

Career Highlights

Ana is affiliated with the Universidad de Granada, where she conducts her research and develops her innovative treatments. Her work has garnered attention for its potential to improve cancer therapies and enhance patient outcomes.

Collaborations

Ana collaborates with esteemed colleagues, including Germaine Escames Rosa and Darío Acuña Castroviejo. Their combined expertise contributes to the advancement of research in the field of oncology.

Conclusion

Ana Guerra-Librero Rite is a trailblazer in the use of melatonin for tumor treatment, showcasing the potential of innovative approaches in medicine. Her contributions are paving the way for new therapeutic options in cancer care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…